Anhui Golden Seed Winery Co., Ltd. engages primarily in the production and sales of baijiu and other alcoholic beverages in China. The company offers a range of Luzhou-flavor baijiu products including the Golden Seed series, Seed series, Zui Sanqiu series, Yingzhou series, Jinzhongzi, Zhongzi, Hetai, Golden Seed Fuhexiang Baijiu, and others; it also produces and sells wines, beer, beverages, and refined tea, alongside ancillary activities such as packaging materials manufacturing, raw materials procurement for liquor production, general freight services, import and export of commodities and technologies, and previously western and traditional Chinese medicines. Founded in 1998 and headquartered in Fuyang, Anhui Province, the company operates principally within China, targeting domestic consumers through its branded liquor portfolio. In recent developments, Anhui Golden Seed Winery completed the disposal of its subsidiary Anhui Jintaiyang Biochemical Pharmaceutical (also referred to as Golden Sun Pharmaceutical) via public listing procedures, with ongoing announcements regarding the transfer of a 92% equity stake in Goldsun Pharmaceutical as of mid-2025, streamlining its focus on core liquor operations. The company continues to report periodic business updates, including third-quarter 2025 financial data, amid a competitive landscape in China's distilled spirits sector.